Study Group: Physicians who Treat Ulcerative Colitis (US)(?)
Council Members in this Study Group: 71
Request a survey with this Study Group
Leading Experts in this Study Group
Carlos Dujovne, MD
Professor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC
Carlos Dujovne, MD, is an Internist, Gastroenterologist, Clinical Pharmacologist, Certified Clinical Lipidologist, Fr. Prof. of Medicine and Pharmacology, and Director of Clinical Pharmacology's Lipid-Arteriosclerosis Prevention-Treatment Clinic in Dept. of Medicine and Pharmacology at University of...
Michael BlumeGastroenterologist
Metropolitan Medical Associates
Michael Blume, MD, is a Gastroenterologist at the Metropolitan Medical Associates in Baltimore, Maryland. In addition to being in full-time private practice, he has extensive experience in utilization management and quality improvement. Dr. Blume has done consulting work for various clinical efficiency...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Crestor's results in the Jupiter Study likely to change medical-economic perspectives in statin choices.
1:Crestor is the most potent statin in the market,yet is 3d in sales behind Zocor and Lipitor.2:The efficacy supriority together with its capacity to lower CRP levels led to the highest rate of ASCVD prevention in the shortest period of time evr documented in statin trials.3:The trial in near 18,000...
Mutiple causes for no publications of many reports on FDA approved drugs.Some problems and solutions.
This article is not news for clinical researchers like myself that have performed hundreds of clinical trials in collaboration with the Pharmaceutical Industry. Some of the most common reasons for that are: A)Negative studies are difficult to get published.B)Negative results for the dug of the...
Exenatide may provide practical and cost convenient efficacy in tratment of Metabolic Syndrome patients
More than 50% of patients have the 3 ccomponents to qualify for diagnosis of Metabolic Syndrome.Twwo of the components,Diabetes and Obesity are present in 20-25% of them and are difficult to control.Exenatide seems to provide that benefit.
This article (and the NEJM article) restate what is known to those who have used a wide variety of EMR software packages: poor UI, outrageously expensive support contracts and the general reluctance of older physicians to embrace PC-based technologies. There is nothing intuitive about using a computer...
This study, although an abstract has no statistical power. Even a quick overview reveals that the ß for this study is insufficient to make the (marginallY) "significant" results achieved newsworthy. I understand the importance of disseminating information but this article fails in that regard.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Government/Military Hospital or Clinic
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- Owner
- Partner
- Director